2. 国際ガイドライン
The American Association for Thoracic
Surgery (AATS) consensus guidelines for the
management of empyema 2017
British Thoracic Society (Thorax 2010;
65(Suppl2): ii41-ii53
European Association for Cardio-Thoracic
Surgery (Eur J Cardiothorac Surg. 2015;
48(5):642-653)
4. 根拠論文
J L Ulmer et al.
Image-guided catheter drainage of the infected pleural space
J Thorac Imaging. (1991) 6:65-73
画像ガイド下による小型ドレーン留置は
104人の膿胸患者で81%の治癒率が報告
されている
6. 根拠論文(繊維素融解薬)
Surinder Janda et al. (2012)
Intrapleural fibrinolytic therapy for treatment of adult parapneumonic
effusions and empyemas: a systematic review and meta-analysis
Chest. (2012) 142(2) :401-411
治療失敗例や外科的介入のみの結果には
有益であったが、入院期間や死亡には統計
学的優位な差はなかった
7. 根拠論文(手術)
Anthony Chambers et al.
Is video-assisted thoracoscopic surgical decortication superior to
open surgery in the management of adults with primary empyema?
Interact Cardiovasc Thorac Surg.(2010) 11(2):117-7
VATSは入院期間、術後合併症を低下させ
るため、手術に適した膿胸患者の開胸手
術の前に検討する必要がある
9. Retrospective Study
Najib M Rahman et al.
A clinical score (RAPID) to identify those at
risk for poor outcome at presentation in patients
with pleural infection
Chest. (2014). 145(4):848-855
10. TRIPOD
Type of study:後ろ向きコホート研究
Research objectives:妥当性のある新規予後モデルの開発
Index rule:5項目を用いて、0-2点をlow・3-4点をmedium・5-7点をhigh
riskとする(次スライド)
Participants:イギリスの膿胸患者
Outcome:ランダム化3ヶ月後の死亡率、ランダム化後から退院までの入
院期間、3ヶ月以内の手術必要患者率
Diagnostic/prognostic performance measures:各classでの結果の比較
19. Retrospective Study
Sunkaru Touray et al.
Risk Stratification in Patients with Complicated
Parapneumonic Effusions and Empyema Using
the RAPID Score
Lung. (2018). 196:623-629
20. TRIPOD
Type of study:後向きコホート研究
Research objectives:RAPID scoreのexternal validationの検証
Index rule:RAPID scoreの5項目を用い、0-2点をlow・3-4点を
medium・5-7点をhigh riskとする
Participants:次スライドに示す
Outcome:次スライドに示す
Diagnostic/prognostic performance measures:各classでの結果の
比較
29. Prospective Study
John P. Corcoran et al.
Prospective validation of the RAPID clinical
risk prediction score in adult patients with pleural
infection: the PILOT study
Eur Respir J . (2020). 56: 2000130
30. TRIPOD
Type of study:前向きコホート研究
Research objectives:前向き研究としてRAPID scoreのvalidationを検証
すること
Index rule:RAPID scoreの5項目を用い、0-2点をlow・3-4点を
medium・5-7点をhigh riskとする
Participants:次スライドに示す
Outcome:次スライドに示す
Diagnostic/prognostic performance measures:各classでの結果の比較
41. 参考文献
1. The American Association for Thoracic Surgery (AATS) consensus guidelines
for the management of empyema 2017
2. J L Ulmer et al. (1991).Image-guided catheter drainage of the infected pleural
space. J Thorac Imaging. 6:65-73
3. Surinder Janda et al. (2012). Intrapleural fibrinolytic therapy for treatment of
adult parapneumonic effusions and empyemas: a systematic review and meta-
analysis. Chest. 142(2):401-411
4. Surinder Janda et al. (2012). Intrapleural fibrinolytic therapy for treatment of
adult parapneumonic effusions and empyemas: a systematic review and meta-
analysis. Chest. 142(2):401-411
5. Najib M Rahman et al. (2014).A clinical score (RAPID) to identify those at
risk for poor outcome at presentation in patients with pleural infection. Chest.
145(4):848-855
6. Sunkaru Touray et al. (2018).Risk Stratification in Patients with Complicated
Parapneumonic Effusions and Empyema Using the RAPID Score. Lung.
196:623-629
7. John P. Corcoran et al. (2020). Prospective validation of the RAPID clinical
risk prediction score in adult patients with pleural infection: the PILOT study.
Eur Respir J . 56: 2000130